<DOC>
	<DOCNO>NCT00485433</DOCNO>
	<brief_summary>The purpose study evaluate three dose level SKY0402 compare 105 mg bupivacaine HCl .</brief_summary>
	<brief_title>Dose-ranging Study Postoperative Analgesia Subjects Undergoing Primary Unilateral Inguinal Hernia Repair</brief_title>
	<detailed_description>Effective postoperative pain control critical element patient recovery , majority patient may experience significant pain , particularly first day follow surgery . Appropriate postoperative pain management contribute improved healing , faster patient mobilization , shorten hospital stay , reduce healthcare cost .</detailed_description>
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Hernia , Inguinal</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>1 . Males 18 year age old Screening Visit . 2 . Scheduled undergo , elective , primary , unilateral , opentechnique , tensionfree ( Lichtensteintype technique mesh ) inguinal hernia repair general anesthesia . 3 . American Society Anesthesiology ( ASA ) Physical Class 13 . 4 . Capable willing comply study visit procedure provide write informed consent . 5 . Able speak , read , understand language inform consent form , study questionnaire , instrument use collect subjectreported outcome , order enable accurate appropriate response pain scale require study assessment . 1 . Use following medication within time specify surgery : Longacting opioid medication within 3 day . Any opioid medication within 24 hour . 2 . Concurrent painful physical condition may require analgesic treatment postoperative period pain strictly relate hernia repair procedure may confound postoperative assessment ( e.g. , rheumatoid arthritis , neuropathic pain , concomitant vasectomy ) . 3 . Body weight less 50 kilogram . 4 . History hypersensitivity idiosyncratic reaction amidetype local anesthetic . 5 . Other contraindication bupivacaine . 6 . Contraindication ( ) epinephrine , concurrent administration monoamine oxidase ( MAO ) inhibitor antidepressant amitriptyline imipramine type , condition production exacerbation tachycardia could prove fatal ( e.g. , poorly control thyrotoxicosis severe heart disease ) , pathological condition might aggravate effect epinephrine . 7 . Contraindication pain control agent anticipate use postoperatively ( i.e. , acetaminophen oxycodone ) . 8 . Administration investigational product within 30 day 5 elimination halflives investigational product , whichever longer , prior study drug administration , plan administration another investigational product procedure subject 's participation study . 9 . Suspected known addiction abuse illicit drug ( ) , prescription medicine ( ) , alcohol within past 2 year . 10 . Uncontrolled anxiety , schizophrenia , psychiatric disorder , opinion Investigator , may interfere study assessment compliance . 11 . Current historical evidence clinically significant condition , opinion Investigator , may increase risk surgery , complicate subject 's postoperative course , indicate increase vulnerability study drug procedure expose subject unreasonable risk result participate clinical trial . If surgery follow criterion meet : 12 . Any clinically significant event condition uncover hernia repair surgery ( e.g. , excessive bleeding ) might render subject medically unstable complicate subject 's postoperative course .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>hernia</keyword>
	<keyword>unilateral</keyword>
	<keyword>postoperative</keyword>
	<keyword>analgesia</keyword>
</DOC>